Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its experimental oral breast cancer drug giredestrant failed to show effectiveness in newly diagnosed patients.
Shares of AstraZeneca, the UK’s largest drugmaker, will begin trading on the New York Stock Exchange on Monday following a listing upgrade that replaces its American Depositary Receipts previously traded on Nasdaq.
09 Mar 2026-13:54
02 Feb 2026-13:55
